EXPRESSION OF CONCERN: Hydroxychloroquine: Pharmacokinetics and Toxicity
Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/jcpt/9791837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 28.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
EXPRESSION OF CONCERN: P. Brouqui, E. Chabriere, and D. Raoult, “Hydroxychloroquine: Pharmacokinetics and Toxicity,” Journal of Clinical Pharmacy and Therapeutics, 2024, 6500340, 12 pages, 2024. https://doi.org/10.1155/2024/6500340. This Expression of Concern is for the above article, published online on 24 January 2024 in Wiley Online Library (https://wileyonlinelibrary.com), and has been issued by John Wiley & Sons Ltd. The Expression of Concern has been agreed due to questions raised about the study’s adherence to French legal and ethical requirements for research involving human subjects. Additionally, concerns have been raised for ten of the referenced articles. The investigation into these concerns is ongoing. Therefore, the journal has decided to issue an Expression of Concern to inform and alert readers.
Zitieren
APA
(2026). EXPRESSION OF CONCERN: Hydroxychloroquine: Pharmacokinetics and Toxicity. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/9791837
Vancouver
EXPRESSION OF CONCERN: Hydroxychloroquine: Pharmacokinetics and Toxicity. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/9791837
BibTeX
@article{euvimed2026,
title = {EXPRESSION OF CONCERN: Hydroxychloroquine: Pharmacokinetics and Toxicity},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jcpt/9791837}
}
EUVIMED